FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

VistaPharm Sucralfate Oral Suspension 1g per 10mL Recall

Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), R…

VistaPharm LLC · Largo, FL

Risk level
Class II
Reported by FDA
Sep 20, 2023
Recall ID
D-1149-2023
Check your lot numberHow we source this data

Summary

VistaPharm recalled Sucralfate Oral Suspension 1g per 10mL starting Aug 30, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1149-2023 on Sep 20, 2023. Reason: Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results. Status: Terminated.

Why it was recalled

Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results

Product description

Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16

Lot numbers, UPCs & expiration codes

Lot #: 921100; Exp. 02/2025

Where it was sold

Distributed nationwide to 68 consignees in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1149-2023
Classification
Class II
Status
Terminated
Recall initiated
Aug 30, 2023
FDA report date
Sep 20, 2023
Quantity
14,400 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
VistaPharm LLC

Original FDA data

Every field from FDA enforcement report D-1149-2023, exactly as published.

Show all FDA fields
City
Largo
State
FL
Status
Terminated
Country
United States
Event ID
92916
Address
7265 Ulmerton Rd
Code information
Lot #: 921100; Exp. 02/2025
Postal code
33771-4809
Report date
Sep 20, 2023
Product type
Drugs
Recall number
D-1149-2023
Classification
Class II
Recalling firm
VistaPharm LLC
Product quantity
14,400 bottles
Termination date
Jul 26, 2024
Reason for recall
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16
Distribution pattern
Distributed nationwide to 68 consignees in the U.S.
Recall initiation date
Aug 30, 2023
Initial firm notification
Letter
Center classification date
Sep 11, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1149-2023, published Sep 20, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls